TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.39, ss.73-76, 2009 (SCI İndekslerine Giren Dergi)
Aims: It is known that there is a relationship between diabetic complications and chronic inflammation characterized by alterations in circulating acute phase proteins. It has been emphasized that inflammation contributes to diabetic complications and that gliclazide -an antidiabetic sulfonylurea - decreases the development of such complications. In this study, we aimed to investigate whether gliclazide or diet treatment has an effect on serum levels of acute phase reactants. markers of inflammation.